Messe Muenchen India, a subsidiary of Messe München GmbH and a leading organiser of B2B trade fairs in India, has acquired PharmaTech Expo from PharmaTechnologyindex.com Pvt. Ltd., an Ahmedabad-based company and a division of KNS Group. The acquisition strengthens Messe Muenchen India’s presence in the pharmaceutical manufacturing and laboratory technology sectors by adding an established exhibition platform spanning 30,000 square metres. PharmaTech Expo focuses on pharmaceutical manufacturing technologies, production systems and plant infrastructure. With this acquisition, Messe Muenchen India aims to expand its industry reach and create new opportunities for pharmaceutical manufacturers, technology providers and other stakeholders.
PharmaTech Expo Connects Pharmaceutical Manufacturers and Technology Providers
Over the years, PharmaTech Expo has become an important meeting point for pharmaceutical manufacturers, technology providers and industry professionals across western and northern India. The exhibition attracts more than 750 exhibitors and over 30,000 visitors, showcasing solutions for pharmaceutical machinery, processing and production equipment, cleanroom technologies, plant utilities, packaging systems, laboratory solutions and allied services. Following the acquisition, the exhibition will retain its regional strengths, established industry relationships and market relevance. At the same time, it will benefit from Messe Muenchen India’s broader industry network, international expertise and organisational capabilities.
Messe München Strengthens Its Commitment to India’s Pharmaceutical Industry
Dr. Reinhard Pfeiffer and Stefan Rummel, CEOs of Messe München Group, said the acquisition complements the company’s analytica cluster and reinforces its long-term commitment to India. They highlighted India’s growing importance in the global pharmaceutical industry, supported by its strong manufacturing capabilities, expanding research landscape, high-quality standards and resilient supply chains. By combining PharmaTech Expo’s regional expertise with Messe München’s international network and experience in organising leading life science and biochemistry exhibitions, the group aims to create lasting value for exhibitors, visitors and the wider pharmaceutical community.
PharmaTech Expo 2027 Dates and Venues Announced
PharmaTech Expo will continue as scheduled at its upcoming editions in 2027:
Chandigarh: April 8–10, 2027
Gandhinagar: August 5–7, 2027, at the Helipad Exhibition Centre
The continuation of these events will help maintain PharmaTech Expo’s established presence in key regional pharmaceutical markets while supporting industry networking, technology exchange and business development.
Integrated Portfolio Covers the Pharmaceutical Value Chain
With PharmaTech Expo joining its portfolio, Messe Muenchen India will bring together three complementary platforms: analytica Lab India, PharmaCore India and PharmaTech Expo.
Together, these exhibitions will address different stages of the pharmaceutical and laboratory value chain, including laboratory research, analytical testing, diagnostics, active pharmaceutical ingredients (APIs), formulations, contract manufacturing, production technologies, plant engineering, cleanrooms, utilities and packaging solutions.
This integrated portfolio will serve pharmaceutical manufacturers, laboratory professionals, production and plant managers, procurement teams, quality specialists, researchers, technology providers and other industry stakeholders.
Messe Muenchen India Aims to Drive Collaboration and Innovation
Bhupinder Singh, President IMEA, Messe München, and CEO of Messe Muenchen India, described the acquisition as an important step towards strengthening the company’s role as a strategic partner to India’s pharmaceutical and laboratory industries.
He explained that bringing specialised exhibition platforms together under one portfolio would create an ecosystem connecting technology leaders, manufacturers and decision-makers. This approach is expected to encourage collaboration, accelerate technology adoption and support business growth across the sector.
He also emphasised the importance of developing industry platforms that respond to evolving business requirements while creating opportunities for knowledge exchange and strategic partnerships.
PharmaTech Expo’s Founders Welcome the Acquisition
Aarjav Shah and Ramesh Shah, Directors of PharmaTechnologyindex.com Pvt. Ltd., a division of KNS Group, highlighted PharmaTech Expo’s growth as an important platform for interaction among pharmaceutical manufacturers, technology providers and industry professionals in key regional markets.
They noted that joining the Messe Muenchen India portfolio would combine the exhibition’s established industry relationships with the group’s global capabilities and market reach. They also expressed confidence that the acquisition would create new opportunities for exhibitors, partners and the broader pharmaceutical manufacturing ecosystem.
Acquisition Expands Opportunities for India’s Pharmaceutical Sector
The acquisition of PharmaTech Expo marks a strategic expansion of Messe Muenchen India’s pharmaceutical and laboratory exhibition portfolio. By combining regional market knowledge with international expertise, the company aims to strengthen industry connections and provide a broader platform for showcasing manufacturing technologies and laboratory solutions.
Each exhibition will retain its distinct identity and market focus while contributing to a connected portfolio designed to meet the evolving needs of India’s pharmaceutical and laboratory industries. As a result, the expanded platform is positioned to support technology development, business networking and collaboration across the pharmaceutical value chain.
